# Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer

> **NCT01142102** · NA · COMPLETED · sponsor: **Trans Tasman Radiation Oncology Group** · enrollment: 50 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT01142102
- **Lead sponsor:** Trans Tasman Radiation Oncology Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-02
- **Final completion:** 2015-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01142102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01142102, "Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01142102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*